Production (Stage)
Tonix Pharmaceuticals Holding Corp.
TNXP
$28.93
$2.539.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 131.72M | 98.78M | 28.23M | 4.16M | 7.05M |
| Total Receivables | 4.46M | 7.82M | 9.42M | 3.34M | -- |
| Inventory | 8.14M | 8.41M | 8.27M | 9.46M | 12.35M |
| Prepaid Expenses | 2.36M | 2.45M | 2.49M | 7.44M | 10.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.90M | 1.55M | 2.13M | 900.00K | -- |
| Total Current Assets | 149.57M | 119.00M | 50.54M | 25.29M | 30.10M |
|
|
|||||
| Total Current Assets | 149.57M | 119.00M | 50.54M | 25.29M | 30.10M |
| Net Property, Plant & Equipment | 42.27M | 42.82M | 43.38M | 43.94M | 93.82M |
| Long-term Investments | -- | -- | -- | -- | 965.00K |
| Goodwill | -- | -- | -- | -- | 965.00K |
| Total Other Intangibles | 120.00K | 120.00K | 120.00K | 120.00K | 9.51M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 910.00K | 951.00K | 951.00K | 961.00K | 960.00K |
| Total Assets | 192.87M | 162.89M | 94.99M | 70.31M | 135.34M |
|
|
|||||
| Total Accounts Payable | 4.19M | 4.55M | 3.94M | 10.41M | 6.65M |
| Total Accrued Expenses | 3.78M | 7.01M | 4.32M | 4.81M | 10.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 235.00K | 3.09M | 3.10M | 3.10M | 3.10M |
| Total Finance Division Other Current Liabilities | 3.94M | 3.66M | 3.83M | 3.73M | -- |
| Total Other Current Liabilities | 3.94M | 3.66M | 3.83M | 3.73M | -- |
| Total Current Liabilities | 12.15M | 18.31M | 15.18M | 22.04M | 20.48M |
|
|
|||||
| Total Current Liabilities | 12.15M | 18.31M | 15.18M | 22.04M | 20.48M |
| Long-Term Debt | -- | 4.67M | 5.17M | 5.67M | 6.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 328.00K | 358.00K | 425.00K | 493.00K | 563.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.47M | 23.33M | 20.78M | 28.20M | 27.20M |
|
|
|||||
| Common Stock & APIC | 928.19M | 870.51M | 783.05M | 736.72M | 723.98M |
| Retained Earnings | -747.52M | -730.69M | -708.59M | -694.37M | -615.60M |
| Treasury Stock & Other | -266.00K | -255.00K | -250.00K | -243.00K | -240.00K |
| Total Common Equity | 180.40M | 139.56M | 74.21M | 42.10M | 108.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 180.40M | 139.56M | 74.21M | 42.10M | 108.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 180.40M | 139.56M | 74.21M | 42.10M | 108.14M |
|
|
|||||